drugset / Trial / NCT03331302

Hyper Polarized Xenon-129 MRI vs Xenon-133 Scintigraphy

NCT03331302

Phase 1/2 Recruiting 30 enrolled University of Virginia
Non-randomizedCrossoverOpen-labelDiagnostic

Summary

Hyper polarized Xenon-129 MRI will be directly compared to a radioactive Xe-133 scintigraphy to detect defects in lung ventilation from airflow limitation. This study is conducted as a pilot study with intention to conduct a larger clinical trial.

Timeline

Start
2018-09-01
Primary completion
2020-06-30
Completion
2020-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Xenon-129 Diagnostic / imaging agent Inhaled
Comparator Xenon-133 Diagnostic / imaging agent Inhaled